Document Detail


Evaluation of a novel assay for detection of the fetal marker RASSF1A: facilitating improved diagnostic reliability of noninvasive prenatal diagnosis.
MedLine Citation:
PMID:  23024794     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Analysis of cell free fetal (cff) DNA in maternal plasma is used routinely for non invasive prenatal diagnosis (NIPD) of fetal sex determination, fetal rhesus D status and some single gene disorders. True positive results rely on detection of the fetal target being analysed. No amplification of the target may be interpreted either as a true negative result or a false negative result due to the absence or very low levels of cffDNA. The hypermethylated RASSF1A promoter has been reported as a universal fetal marker to confirm the presence of cffDNA. Using methylation-sensitive restriction enzymes hypomethylated maternal sequences are digested leaving hypermethylated fetal sequences detectable. Complete digestion of maternal sequences is required to eliminate false positive results.
METHODS: cfDNA was extracted from maternal plasma (n = 90) and digested with methylation-sensitive and insensitive restriction enzymes. Analysis of RASSF1A, SRY and DYS14 was performed by real-time PCR.
RESULTS: Hypermethylated RASSF1A was amplified for 79 samples (88%) indicating the presence of cffDNA. SRY real time PCR results and fetal sex at delivery were 100% accurate. Eleven samples (12%) had no detectable hypermethylated RASSF1A and 10 of these (91%) had gestational ages less than 7 weeks 2 days. Six of these samples were male at delivery, five had inconclusive results for SRY analysis and one sample had no amplifiable SRY.
CONCLUSION: Use of this assay for the detection of hypermethylated RASSF1A as a universal fetal marker has the potential to improve the diagnostic reliability of NIPD for fetal sex determination and single gene disorders.
Authors:
Helen E White; Carolyn L Dent; Victoria J Hall; John A Crolla; Lyn S Chitty
Related Documents :
24439164 - Setting up equine embryo gender determination by preimplantation genetic diagnosis in a...
7340084 - Susceptibility to african trypanosomiasis of n'dama and zebu cattle in an area of gloss...
17085734 - Weaning weight inheritance in environments classified by maternal body weight change.
17032804 - Technical note: exit velocity as a measure of cattle temperament is repeatable and asso...
9216254 - Characteristics of winter and summer aerosol mass and light extinction on the colorado ...
22696814 - Imaging practices in the diagnosis and management of gestational trophoblastic disease:...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2012-09-14
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-01     Completed Date:  2013-02-15     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e45073     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Cell Cycle Proteins / genetics
Cell-Free System
DNA / blood
Female
Humans
Male
Pregnancy
Prenatal Diagnosis / methods*
Real-Time Polymerase Chain Reaction
Reproducibility of Results
Sex Determination Analysis / methods*
Tumor Suppressor Proteins / genetics*
Young Adult
Grant Support
ID/Acronym/Agency:
RP-PG-0707-10107//Department of Health
Chemical
Reg. No./Substance:
0/Cell Cycle Proteins; 0/RASSF1 protein, human; 0/Tumor Suppressor Proteins; 9007-49-2/DNA
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  FliC, a flagellin protein, is essential for the growth and virulence of fish pathogen Edwardsiella t...
Next Document:  A peak-clustering method for MEG group analysis to minimise artefacts due to smoothness.